Review paper <BR>Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance

Mariusz Puszczewicz

Abstract

3/2006 vol. 44

Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance

Mariusz Puszczewicz

RU 2006; 44, 3: 169–175

Online publish date: 2006/06/26

View full text

AMA

Puszczewicz M. Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance. Reumatologia/Rheumatology. 2006;44(3):169-175.

APA

Puszczewicz, M. (2006). Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance. Reumatologia/Rheumatology, 44(3), 169-175.

Chicago

Puszczewicz, Mariusz. 2006. "Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance". Reumatologia/Rheumatology 44 (3): 169-175.

Harvard

Puszczewicz, M. (2006). Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance. Reumatologia/Rheumatology, 44(3), pp.169-175.

MLA

Puszczewicz, Mariusz. "Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance." Reumatologia/Rheumatology, vol. 44, no. 3, 2006, pp. 169-175.

Vancouver

Puszczewicz M. Review paper Antinuclear antibodies in systemic sclerosis – antigen specificity and clinical significance. Reumatologia/Rheumatology. 2006;44(3):169-175.

This article briefly reviews the structure and function of molecules targeted by specific for systemic sclerosis antinuclear antibodies. Moreover emphasizes ANA clinical relationships and methods of their detection.